Landmark paper highlights Evox Therapeutics' cutting edge exosome engineering approach for enhanced surface display of biologics

OXFORD, England, Oct. 7, 2021 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, announces that it has, in close collaboration with one of its co-founder's lab at the Karolinska Institute, published a landmark paper in Nature...

from PR Newswire: https://ift.tt/3mqWPBI